The study concludes that the high-tech start-up companies are among the first to perish in the midst of a global financial crisis. The small biotech company BerGenBio AS, a BTO startup company, is an example of the oposite. Before Christmas 2011, the company accomplished to raise substantial funding from investors, 52 mill NOK in equity capital.Read complete article here
BT has interviewed Richard Godfrey, the CEO of BerGenBio, about how they have managed to overcome the challenges of the financial crisis and accomplished to raise funding and growth. Read the whole article here (no longer available).